\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ lumbar\\ puncture\\ was\\ preformed\\.\ \(0\)\
\-\ two\\ new\\ lesions\\ are\\ seen\\ in\\ the\\ brain\\ in\\ opposite\\ hemispheres\\ that\\ are\\ oviod\\,\\ homogeneously\\ hyperdense\\ and\\ enhancing\\,\\ t1\\ dark\\ and\\ t2\\ bright\\ with\\ restricted\\ difussion\\.\\ \ \(0\)\
\-\ no\\ occular\\ abnormalities\\.\ \(0\)\
\-\ lymphoma\\,\\ cns\ \(0\)\
\-\ primary\\ brain\\ malignancy\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ lymphoma\ \(373\)\
\-\ abscess\ \(594\)\
\-\ sarcoid\ \(163\)\
\-\ ms\ \(3148\)\
\-\ pml\ \(0\)\
\-\ toxoplasmosis\ \(14\)\
\-\ known\\ diffuse\\ large\\ b\\-cell\\ lymphoma\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lymphoma\\:\\ 0\\.2962960276203536\ \(0\)\
\-\ oviod\\:\\ 0\\.26520715760391783\ \(0\)\
\-\ difussion\\:\\ 0\\.26520715760391783\ \(0\)\
\-\ occular\\:\\ 0\\.25341959747571313\ \(0\)\
\-\ pml\\:\\ 0\\.22878720796527227\ \(0\)\
\-\ preformed\\:\\ 0\\.21079068558915204\ \(0\)\
\-\ brain\\:\\ 0\\.2067628961120595\ \(0\)\
\-\ opposite\\:\\ 0\\.1954962647452694\ \(0\)\
\-\ toxoplasmosis\\:\\ 0\\.18647953360532324\ \(0\)\
\-\ puncture\\:\\ 0\\.1811791359375582\ \(0\)\
\-\ homogeneously\\:\\ 0\\.17281572892911276\ \(0\)\
\-\ dark\\:\\ 0\\.1626898610809537\ \(0\)\
\-\ hemispheres\\:\\ 0\\.1610281688009081\ \(0\)\
\-\ ms\\:\\ 0\\.1610281688009081\ \(0\)\
\-\ sarcoid\\:\\ 0\\.15552658209242673\ \(0\)\
\-\ cns\\:\\ 0\\.15486583318745764\ \(0\)\
\-\ hyperdense\\:\\ 0\\.1526647617924627\ \(0\)\
\-\ bright\\:\\ 0\\.1511887239627702\ \(0\)\
\-\ restricted\\:\\ 0\\.1425388939443036\ \(0\)\
\-\ lumbar\\:\\ 0\\.13390950429037973\ \(0\)\
\-\ are\\:\\ 0\\.12585410319181128\ \(0\)\
\-\ malignancy\\:\\ 0\\.12415038764736716\ \(0\)\
\-\ abnormalities\\:\\ 0\\.12012679678847168\ \(0\)\
\-\ new\\:\\ 0\\.11472768357472946\ \(0\)\
\-\ no\\:\\ 0\\.10785567205608954\ \(0\)\
\-\ known\\:\\ 0\\.10736684834348939\ \(0\)\
\-\ abscess\\:\\ 0\\.10648772346241896\ \(0\)\
\-\ diffuse\\:\\ 0\\.10399942051071705\ \(0\)\
\-\ enhancing\\:\\ 0\\.10388608040475274\ \(0\)\
\-\ t1\\:\\ 0\\.10332591470512768\ \(0\)\
\-\ primary\\:\\ 0\\.10197097702552496\ \(0\)\
\-\ two\\:\\ 0\\.09848217438879096\ \(0\)\
\-\ t2\\:\\ 0\\.09540977344720285\ \(0\)\
\-\ lesions\\:\\ 0\\.09524124137894892\ \(0\)\
\-\ metastatic\\:\\ 0\\.09095250703687677\ \(0\)\
\-\ large\\:\\ 0\\.08309184593869377\ \(0\)\
\-\ in\\:\\ 0\\.08250900890131631\ \(0\)\
\-\ seen\\:\\ 0\\.07807403733715298\ \(0\)\
\-\ that\\:\\ 0\\.07196641249855945\ \(0\)\
\-\ disease\\:\\ 0\\.06961187533194178\ \(0\)\
\-\ and\\:\\ 0\\.06853577493270899\ \(0\)\
\-\ was\\:\\ 0\\.05779533334473516\ \(0\)\
\-\ the\\:\\ 0\\.03309020255007025\ \(0\)\
\-\ with\\:\\ 0\\.032472675244809505\ \(0\)\
